Comments
Dr Reddy’s Laboratories Ltd has launched Testosterone Gel, a therapeutic equivalent generic version of AndroGel (testosterone gel) which is approved by the US Food and Drug Administration (USFDA).
The AndroGel brand and generic had US sales of approximately $815.6 million for the most recent twelve months ending in February 2019 according to IQVIA Health, the company said in a release.
Dr Reddy’s testosterone gel is available in a net quantity of 88 g pump which dispenses 20.25 mg of testosterone per actuation. Each metered-dose pump is capable of dispensing 60 metered pump actuations.
Shares of Dr Reddy’s Laboratories were trading at Rs 2,908.20, up 0.15 per cent on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.